{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "multicenter retrospective study"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "All 194 patients were divided into CS (94 patients) and DCB (100 patients) groups"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the midterm efficacy of CS and DCB procedures in patients with FPO."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary end point was primary patency at 24\u2009months"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "All 194 patients were divided into CS (94 patients) and DCB (100 patients) groups"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "the CS used (hazard ratio [HR], 0.54 [95% CI, 0.32\u20130.91], P =0.021)"
      },
      "Harms": {
        "score": 1,
        "evidence": "major adverse events"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 10,
    "max_score": 25
  },
  "model": "gpt-4o"
}